Impact of Paradoxical Decrease in High-density Lipoprotein Cholesterol Levels After Statin Therapy on Major Adverse Cardiovascular Events in Patients with Stable Angina Pectoris-Reference-Cited by-同舟云学术

Impact of Paradoxical Decrease in High-density Lipoprotein Cholesterol Levels After Statin Therapy on Major Adverse Cardiovascular Events in Patients with Stable Angina Pectoris

Published:2017-02 Issue:2 Volume:39 Page:279-287
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Hirayama Kenshi,Ota Tomoyuki,Harada Kazuhiro,Shibata Yohei,Tatami Yosuke,Harata Shingo,Kawashima Kazuhiro,Kunimura Ayako,Shimbo Yusaku,Takayama Yohei,Kawamiya Toshiki,Yamamoto Dai,Osugi Naohiro,Suzuki Susumu,Ishii Hideki,Murohara Toyoaki

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference33 articles.

1. Intensive versus moderate lipid lowering with statins after acute coronary syndromes;Cannon;N Engl J Med,2004

2. Intensive lipid lowering with atorvastatin in patients with stable coronary disease;LaRosa;N Engl J Med,2005

3. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials;Baigent;Lancet,2010

4. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial;Nissen;JAMA,2004

5. Optical coherence tomography patterns of stent restenosis;Gonzalo;Am Heart J,2009

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SLCO1B1 and ABCB1 variants synergistically influence the atorvastatin treatment response in South Indian coronary artery disease patients;Pharmacogenomics;2022-08

2. Association of fasting blood glucose to high-density lipoprotein cholesterol ratio with short-term outcomes in patients with acute coronary syndrome;Lipids in Health and Disease;2022-01-30

3. EFFECT OF DIFFERENT DOSES OF ROSUVASTATIN ON SERUM HDL SUBTYPES IN PATIENTS WITH HYPERLIPIDEMIA AND CORONARY HEART DISEASE;ACTA MEDICA MEDITERR;2022

4. Increasing HDL-C levels with medication;Current Opinion in Lipidology;2017-08